View up-to-date information on NGM Biopharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| CO2022008272A2 | Application | Agentes de unión a ilt3 y métodos de uso de los mismos | A61K2039/505; C07K16/2803; C07K2317/24; C07K2317/33; C07K2317/565; C07K2317/76; C07K2317/92 | August 30, 2022 |
| WO2022170166A1 | Application | HTRA1-BINDING AGENTS AND METHODS OF USE THEREOF | A61K2039/505; A61K31/7105; A61K38/179; A61K39/00; A61K39/3955; C07K16/40; C07K2317/24; C07K2317/31; C07K2317/34; C07K2317/51; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 | August 11, 2022 |
| US20220251241A1 | Application | HTRA1-BINDING AGENTS AND METHODS OF USE THEREOF | A61K31/7105; A61K38/179; A61K39/00; A61K39/3955; C07K16/40; C07K2317/24; C07K2317/31; C07K2317/51; C07K2317/56; C07K2317/565 | August 11, 2022 |
| US20220241373A1 | Application | METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES | A61K31/155; A61K31/165; A61K31/519; A61K31/52; A61K31/573; A61K31/575; A61K31/64; A61K38/13; A61K38/1825; A61K38/208; A61K38/26; A61K38/28; A61K45/06; C07K14/50; C07K2319/00 | August 04, 2022 |
| CA2899170C | Grant | COMPOSITIONS AND METHODS OF USE IN TREATING METABOLIC DISORDERS | A61K38/00; A61K38/18; A61K38/1841; A61P3/04; A61P3/08; A61P3/10; A61P43/00; C07K14/475; C07K14/495; C07K14/765; C07K2319/30; C07K2319/31 | August 02, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward